Preoperative assessment of CD44‐mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma
- 18 December 2018
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 41 (4) , 950-958
Abstract
Background: Epithelial–mesenchymal transition and cancer stem‐like cells (CSC) have been linked to increased metastatic potential. We evaluated the prognostic impact of CD44, a CSC biomarker, on depth of invasion (DOI) and outcome in oral squamous cell carcinoma (OSCC).Methods: Using a multivariable logistic regression model, we evaluated in early OSCCs the relationship between CD44 expression at the invasive tumor front, DOI, sentinel lymph node biopsy, extension of nodal involvement, and survival. We also assessed whether CT and/or MRI could predict DOI preoperatively.Results: CD44 expression was associated with increased DOI (P = .018), worse disease‐specific survival (P = .041) but not with positive sentinel lymph node biopsy (P > .05). Each millimeter increase in DOI was associated with a 31.1% higher risk for positive sentinel lymph node biopsy (95% CI: 5.8%‐62.4%, P = .013) and with higher metastatic ratio (P = .015). Preoperative estimation of DOI by CT and/or MRI and histopathological DOI showed a strong correlation (P < .0001).Conclusions: CD44 expression correlates with DOI, which predicts occult lymph node metastasis. Preoperative CT and/or MRI provides an accurate estimation of histopathological DOI. Both pieces of information gained preoperatively can help surgeons tailor their operation in regard to the surgical management of the neck.Keywords
This publication has 41 references indexed in Scilit:
- Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysisBMC Cancer, 2014
- CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal TransitionPLOS ONE, 2013
- p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humansEMBO Molecular Medicine, 2012
- Recurrent Oral Cancer: Current and Emerging Therapeutic ApproachesFrontiers in Pharmacology, 2012
- ERK1/2 Regulation of CD44 Modulates Oral Cancer AggressivenessCancer Research, 2012
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cellsOncogene, 2011
- Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenaseHead & Neck, 2010
- Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neckOral Oncology, 2009
- Predictive value of tumor thickness for cervical lymph‐node involvement in squamous cell carcinoma of the oral cavityCancer, 2009
- Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProceedings of the National Academy of Sciences, 2007